Literature DB >> 28338663

Prevalence and associated factors of blepharoptosis in Korean adult population: The Korea National Health and Nutrition Examination Survey 2008-2011.

M H Kim1,2, J Cho3,4,5, D Zhao3, K I Woo6, Y-D Kim6, S Kim7, S W Yang8.   

Abstract

PurposeThis study aimed to evaluate the prevalence and associated factors of involutional blepharoptosis in a nationwide representative sample in Korea.MethodsCross-sectional study 20 941 Korean men and women 40 years of age and older who participated in last 2 years (2008 and 2009) of the 4th wave of the Korean National Health and Nutrition Examination Survey (KNHANES) IV and the first 2 years (2010 and 2011) of KNHANES V. Ocular examinations were performed by ophthalmologists trained in procedure and grading methods, and blepharoptosis was defined as a marginal reflex distance <2 mm on either eye.ResultsThe prevalence of involutional blepharoptosis in the Korean adult was 13.5% (95% CI: 12.1%, 14.9%). It was increasing along with aging (5.4% among 40's and 32.8% in people over 70 years old). A statistically significant negative association between levator function and blepharoptosis was found. With right eye, while only 5.4% (95% CI: 4.5%, 6.2%) had blepharoptosis among people whose levator function was excellent (≥12 mm), 71.4% (95% CI: 60.0%, 85.9%) of people whose levator function was poor (≤4 mm) had blepharoptosis. Hypertension, diabetes, higher body mass index (BMI), and lower education had statistically significant association with blepharoptosis adjusting all other confounders.ConclusionsThe distribution and proportional changes of levator function and marginal reflex distance 1 (MRD1) with aging implicate a contributory role of muscular degeneration. Strong association with hypertension, diabetes, BMI, and education level suggests that etiology of involutional blepharoptosis would be multifactorial and further investigation would be necessary to determine precise mechanism and contribution of factors.

Entities:  

Mesh:

Year:  2017        PMID: 28338663      PMCID: PMC5518839          DOI: 10.1038/eye.2017.43

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  26 in total

1.  Maximum angle of ocular duction during visual fixation as a function of age.

Authors:  Diana Shechtman; Josephine Shallo-Hoffmann; Jay Rumsey; Paul Riordan-Eva; Patrick Hardigan
Journal:  Strabismus       Date:  2005-03

2.  Functional indications for upper eyelid ptosis and blepharoplasty surgery: a report by the American Academy of Ophthalmology.

Authors:  Kenneth V Cahill; Elizabeth A Bradley; Dale R Meyer; Philip L Custer; David E Holck; Marcus M Marcet; Louise A Mawn
Journal:  Ophthalmology       Date:  2011-10-22       Impact factor: 12.079

3.  Quantitating the superior visual field loss associated with ptosis.

Authors:  D R Meyer; J V Linberg; S R Powell; J V Odom
Journal:  Arch Ophthalmol       Date:  1989-06

4.  Disinsertion of the aponeurosis of the levator palpebrae superioris muscle after cataract extraction.

Authors:  G L Paris; M H Quickert
Journal:  Am J Ophthalmol       Date:  1976-03       Impact factor: 5.258

5.  Etiological pattern of blepharoptosis among patients presenting in teaching hospital.

Authors:  R Thapa; P C Karmacharya; B P Nepal
Journal:  JNMA J Nepal Med Assoc       Date:  2006 Apr-Jun       Impact factor: 0.406

6.  Anatomic changes in involutional blepharoptosis.

Authors:  J W Shore; C D McCord
Journal:  Am J Ophthalmol       Date:  1984-07-15       Impact factor: 5.258

7.  Gender differences in the association of insulin resistance with metabolic risk factors among Korean adolescents: Korea National Health and Nutrition Examination Survey 2008-2010.

Authors:  Hyun-Ah Kim; Sae-Young Lee; Hyuk-Sang Kwon; Seung-Hwan Lee; Min Ho Jung; Kyungdo Han; Hyeon Woo Yim; Won-Chul Lee; Yong-Moon Park
Journal:  Diabetes Res Clin Pract       Date:  2012-10-27       Impact factor: 5.602

8.  Levator superioris muscle function in involutional blepharoptosis.

Authors:  Luciano S Pereira; Thomas N Hwang; Robert C Kersten; Kathryn Ray; Timothy J McCulley
Journal:  Am J Ophthalmol       Date:  2008-03-28       Impact factor: 5.258

9.  Oxidative stress in the levator aponeurosis in Asian involutional blepharoptosis.

Authors:  Satoru Kase; Mika Noda; Hiroshi Yoshikawa; Teppei Yamamoto; Kan Ishijima; Susumu Ishida
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2014 Jul-Aug       Impact factor: 1.746

10.  Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008-2009.

Authors:  Kyung-Chul Yoon; Gui-Hyeong Mun; Sang-Duck Kim; Seung-Hyun Kim; Chan Yun Kim; Ki Ho Park; Young Jeung Park; Seung-Hee Baek; Su Jeong Song; Jae Pil Shin; Suk-Woo Yang; Seung-Young Yu; Jong Soo Lee; Key Hwan Lim; Hye-Jin Park; Eun-Young Pyo; Ji-Eun Yang; Young-Taek Kim; Kyung-Won Oh; Se Woong Kang
Journal:  Korean J Ophthalmol       Date:  2011-11-22
View more
  7 in total

1.  Oculomics for sarcopenia prediction: a machine learning approach toward predictive, preventive, and personalized medicine.

Authors:  Bo Ram Kim; Tae Keun Yoo; Hong Kyu Kim; Ik Hee Ryu; Jin Kuk Kim; In Sik Lee; Jung Soo Kim; Dong-Hyeok Shin; Young-Sang Kim; Bom Taeck Kim
Journal:  EPMA J       Date:  2022-08-08       Impact factor: 8.836

2.  Blepharoptosis among Korean adults: age-related prevalence and threshold age for evaluation.

Authors:  Ji-Sun Paik; Kyungdo Han; Suk-Woo Yang; Yongkyu Park; Kyungsun Na; Wonkyung Cho; Su-Kyung Jung; Sungeun Kim
Journal:  BMC Ophthalmol       Date:  2020-03-13       Impact factor: 2.209

3.  Association between age-related cataract and blepharoptosis in Korean adults: a population-based study.

Authors:  Kyung-Sun Na; Su-Kyung Jung; Younhea Jung; Kyungdo Han; Jiyoung Lee; Ji-Sun Paik; Suk-Woo Yang
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

Review 4.  A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment options.

Authors:  Jason Bacharach; Wendy W Lee; Andrew R Harrison; Thomas F Freddo
Journal:  Eye (Lond)       Date:  2021-04-29       Impact factor: 3.775

5.  Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.

Authors:  David L Wirta; Michael S Korenfeld; Shane Foster; Robert Smyth-Medina; Jason Bacharach; Shane R Kannarr; Mark J Jaros; Charles B Slonim
Journal:  Clin Ophthalmol       Date:  2021-10-08

6.  Effect of Muller's muscle-conjunctival resection on the upper eyelid crease position in Asian eyelids: a retrospective cohort study.

Authors:  Hung-Ju Chen; Chun-Yuan Wang; Yu-Fang Huang; Yu-Chieh Wu; Li-Chen Wei
Journal:  BMC Ophthalmol       Date:  2022-09-21       Impact factor: 2.086

7.  Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results.

Authors:  Jason Bacharach; David L Wirta; Robert Smyth-Medina; Michael S Korenfeld; Shane R Kannarr; Shane Foster; Mark J Jaros; Charles B Slonim
Journal:  Clin Ophthalmol       Date:  2021-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.